Monitoring Ocular Drug Therapy by Analysis of Aqueous Samples

Ophthalmology

Volumn 116, Issue 11, 2009, Pages 2158-2164

  Campochiaro, Peter A ^a   Choy, David F ^b   Do, Diana V ^a   Hafiz, Gulnar ^a   Shah, Syed Mahmood ^a,c   Nguyen, Quan D ^a   Rubio, Roman ^b   Arron, Joseph R ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GENENTECH INC   (United States)

^c Maryland General Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; RANIBIZUMAB; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

AQUEOUS HUMOR; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CENTRAL RETINA VEIN OCCLUSION; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DRUG MONITORING; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA EDEMA; TISSUE LEVEL;

EID: 70350565956     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.04.038     Document Type: Article

References (15)

1. Aiello L.P., Avery R.L., Arrigg P.G., et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331 (1994) 1480-1487
2. Adamis A.P., Miller J.W., Bernal M.T., et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118 (1994) 445-450
3. Wells J.A., Murthy R., Chibber R., et al. Levels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularisation. Br J Ophthalmol 80 (1996) 363-366
4. Funatsu H., Yamashita H., Noma H., et al. Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema. Am J Ophthalmol 133 (2002) 70-77
5. Funatsu H., Yamashita H., Noma H., et al. Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients. Graefes Arch Clin Exp Ophthalmol 243 (2005) 3-8
6. Noma H., Funatsu H., Yamasaki M., et al. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol 140 (2005) 256-261
7. Noma H., Funatsu H., Yamasaki M., et al. Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye 22 (2008) 42-48
8. Campochiaro P.A., Hafiz G., Shah S.M., et al. Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator. Mol Ther 16 (2008) 791-799
9. Rosenfeld P.J., Brown D.M., Heier J.S., et al., MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355 (2006) 1419-1431
10. Brown D.M., Kaiser P.K., Michels M., et al., ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355 (2006) 1432-1444
11. Nguyen Q.D., Tatlipinar S., Shah S.M., et al. Vascular endothelial growth factor is a critical stimulus for diabetic macular edema. Am J Ophthalmol 142 (2006) 961-969
12. Lima e Silva R., Shen J., Hackett S.F., et al. The SDF-1/CXCR4 ligand/receptor pair is an important contributor to several types of ocular neovascularization. FASEB J 21 (2007) 3219-3230
13. Maier R., Weger M., Haller-Schober E.M., et al. Application of multiplex cytometric bead array technology for the measurement of angiogenic factors in the vitreous. Mol Vis [serial online] 12 (2006) 1143-1147. http://www.molvis.org/molvis/v12/a129/ Accessed April 19, 2009
14. Banerjee S., Savant V., Scott R.A., et al. Multiplex bead analysis of vitreous humor of patients with vitreoretinal disorders. Invest Ophthalmol Vis Sci 48 (2007) 2203-2207
15. Maier R., Weger M., Haller-Schober E.M., et al. Multiplex bead analysis of vitreous and serum concentrations of inflammatory and proangiogenic factors in diabetic patients. Mol Vis [serial online] 14 (2008) 637-643. http://www.molvis.org/molvis/v14/a76/ Accessed April 19, 2009